Literature DB >> 17479310

Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus.

Hasan Otukesh1, Majid Chalian2, Rozita Hoseini1, Hamid Chalian1, Nakysa Hooman1, Arash Bedayat1, Reza Salman Yazdi3, Saeed Sabaghi3, Saeed Mahdavi3.   

Abstract

We reported a series of ten patients with lupus nephritis (five patients in the relapse phase and five in the remission phase) and measured the macrophage migration inhibitory factor (MIF), an important pro-inflammatory cytokine with probable role in the pathogenesis of many inflammatory diseases, in their urine samples. MIF/creatinine (Cr) ratio directly correlated with disease activity and it does not have any significant difference between inactive disease and normal ones. We found that the urine MIF/Cr ratio not only differentiates active disease from inactive disease and normal ones but also correlates with the activity indices of renal pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479310     DOI: 10.1007/s10067-007-0632-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

Review 1.  New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.

Authors:  E F Morand
Journal:  Intern Med J       Date:  2005-07       Impact factor: 2.048

2.  Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.

Authors:  Fiona G Brown; David J Nikolic-Paterson; Prudence A Hill; Nicole M Isbel; John Dowling; Christine M Metz; Robert C Atkins
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

Review 3.  Lupus nephritis: update on pathogenesis and disease mechanisms.

Authors:  M H Foster; V R Kelley
Journal:  Semin Nephrol       Date:  1999-03       Impact factor: 5.299

4.  Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes.

Authors:  Y Mizue; J Nishihira; T Miyazaki; S Fujiwara; M Chida; K Nakamura; K Kikuchi; M Mukai
Journal:  Int J Mol Med       Date:  2000-04       Impact factor: 4.101

Review 5.  Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.

Authors:  Hongqi Lue; Robert Kleemann; Thierry Calandra; Thierry Roger; Jürgen Bernhagen
Journal:  Microbes Infect       Date:  2002-04       Impact factor: 2.700

Review 6.  Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?

Authors:  Alberta Y Hoi; Eric F Morand; Michelle Leech
Journal:  Immunol Cell Biol       Date:  2003-10       Impact factor: 5.126

Review 7.  Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype.

Authors:  Peter K Gregersen; Richard Bucala
Journal:  Arthritis Rheum       Date:  2003-05

Review 8.  Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule.

Authors:  R P Donn; D W Ray
Journal:  J Endocrinol       Date:  2004-07       Impact factor: 4.286

  8 in total
  6 in total

Review 1.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

2.  Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation.

Authors:  Undurti N Das
Journal:  J Inflamm Res       Date:  2010-12-02

Review 3.  Lupus nephritis: current update.

Authors:  Ramesh Saxena; Tina Mahajan; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2011-09-28       Impact factor: 5.156

4.  miR-152 Attenuates the Severity of Lupus Nephritis Through the Downregulation of Macrophage Migration Inhibitory Factor (MIF)-Induced Expression of COL1A1.

Authors:  Jiayi Zheng; Ruru Guo; Yuanjia Tang; Qiong Fu; Jie Chen; Lingling Wu; Lin Leng; Richard Bucala; Yang Song; Liangjing Lu
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

5.  Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.

Authors:  Jorge Ivan Gamez-Nava; Valeria Diaz-Rizo; Edsaul Emilio Perez-Guerrero; Jose Francisco Muñoz-Valle; Ana Miriam Saldaña-Cruz; Nicte Selene Fajardo-Robledo; Heriberto Jacobo-Cuevas; Cesar Arturo Nava-Valdivia; Miriam Fabiola Alcaraz-Lopez; Xochitl Trujillo; Miguel Huerta; Ernesto German Cardona-Muñoz; Laura Gonzalez-Lopez
Journal:  Biomark Res       Date:  2020-10-28

6.  Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus.

Authors:  Rangi Kandane-Rathnayake; Eric F Morand; Fabien B Vincent; Laura Slavin; Alberta Y Hoi; Arthur Richard Kitching; Fabienne Mackay; James Harris
Journal:  Lupus Sci Med       Date:  2018-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.